title: Serum asymmetric dimethylarginine levels in diabetic patients with neuropathy.
abstract: OBJECTIVE
  The goal of our study was to evaluate the role of asymmetric dimethylarginine (ADMA) in patients with diabetic neuropathy.
  
  
  METHODS
  In this study, 58 diabetic patients and 26 healthy volunteers were included. In both groups ADMA measurements were performed together with other biochemical examinations. Nerve conduction studies and Neuropathy Symptom Score (NSS) were administered to the diabetic patients.
  
  
  RESULTS
  ADMA levels were found significantly higher in diabetic patients compared to the control group (p = 0.0001). However, ADMA levels were not statistically significant between diabetic patients with neuropathy and without neuropathy (p = 0.86 and p = 0.47).
  
  
  CONCLUSIONS
  These results demonstrate that there is not any significant relationship between ADMA and diabetic neuropathy.
authors.affiliation: GATA Haydarpaşa Training Hospital, Department of Neurology, Istanbul, Turkey.
authors.forename: Halit
authors.initials: H
authors.lastname: Yaşar
authors.forename: Mehmet Güney
authors.initials: MG
authors.lastname: Senol
authors.forename: Tansel
authors.initials: T
authors.lastname: Kendirli
authors.forename: Yalçın
authors.initials: Y
authors.lastname: Önem
authors.forename: Fatih
authors.initials: F
authors.lastname: Özdağ
authors.forename: Mehmet
authors.initials: M
authors.lastname: Saraçoğlu
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D003929:Diabetic Neuropathies / Q000097:blood; D004594:Electrophysiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: C018524:N,N-dimethylarginine; D001120:Arginine